215 related articles for article (PubMed ID: 20722614)
1. A comparison between bisphosphonates and other treatments for osteoporosis.
Le Goff B; Guillot P; Glémarec J; Berthelot JM; Maugars Y
Curr Pharm Des; 2010; 16(27):3037-44. PubMed ID: 20722614
[TBL] [Abstract][Full Text] [Related]
2. [Therapy of osteoporosis: bisphosphonates, SERM's, teriparatide and strontium].
Uebelhart D; Frey D; Frey-Rindova P; Goerres G; Michel BA
Z Rheumatol; 2003 Dec; 62(6):512-7. PubMed ID: 14685711
[TBL] [Abstract][Full Text] [Related]
3. [Osteoporosis].
Buck G; Perger L; Bischoff-Ferrari HA
Praxis (Bern 1994); 2011 Jul; 100(14):821-32. PubMed ID: 21732293
[No Abstract] [Full Text] [Related]
4. [The necessity of cost-effectiveness analysis in osteoporosis].
Lamy O; Krieg MA
Rev Med Suisse; 2007 Jun; 3(115):1521-5. PubMed ID: 17682796
[TBL] [Abstract][Full Text] [Related]
5. Osteoporosis treatment in postmenopausal women with pre-existing fracture.
Cheng MH; Chen JF; Fuh JL; Lee WL; Wang PH
Taiwan J Obstet Gynecol; 2012 Jun; 51(2):153-66. PubMed ID: 22795089
[TBL] [Abstract][Full Text] [Related]
6. Treatment of post-menopausal osteoporosis: beyond bisphosphonates.
Ishtiaq S; Fogelman I; Hampson G
J Endocrinol Invest; 2015 Jan; 38(1):13-29. PubMed ID: 25194424
[TBL] [Abstract][Full Text] [Related]
7. The cost effectiveness of teriparatide as a first-line treatment for glucocorticoid-induced and postmenopausal osteoporosis patients in Sweden.
Murphy DR; Smolen LJ; Klein TM; Klein RW
BMC Musculoskelet Disord; 2012 Oct; 13():213. PubMed ID: 23110626
[TBL] [Abstract][Full Text] [Related]
8. Management of postmenopausal osteoporosis and the prevention of fractures.
Gambacciani M; Levancini M
Panminerva Med; 2014 Jun; 56(2):115-31. PubMed ID: 24942322
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological management of severe postmenopausal osteoporosis.
Gaudio A; Morabito N
Drugs Aging; 2005; 22(5):405-17. PubMed ID: 15903353
[TBL] [Abstract][Full Text] [Related]
10. [Bisphosphonate].
Hagino H
Nihon Rinsho; 2011 Jul; 69(7):1253-7. PubMed ID: 21774367
[TBL] [Abstract][Full Text] [Related]
11. Current and emerging pharmacologic therapies for the management of postmenopausal osteoporosis.
Lewiecki EM
J Womens Health (Larchmt); 2009 Oct; 18(10):1615-26. PubMed ID: 19857095
[TBL] [Abstract][Full Text] [Related]
12. EMAS clinical guide: selective estrogen receptor modulators for postmenopausal osteoporosis.
Palacios S; Brincat M; Erel CT; Gambacciani M; Lambrinoudaki I; Moen MH; Schenck-Gustafsson K; Tremollieres F; Vujovic S; Rees M; Rozenberg S
Maturitas; 2012 Feb; 71(2):194-8. PubMed ID: 22176952
[TBL] [Abstract][Full Text] [Related]
13. New developments in the treatment of osteoporosis.
Eriksen EF; Halse J; Moen MH
Acta Obstet Gynecol Scand; 2013 Jun; 92(6):620-36. PubMed ID: 22646526
[TBL] [Abstract][Full Text] [Related]
14. Impact of treatments for postmenopausal osteoporosis (bisphosphonates, parathyroid hormone, strontium ranelate, and denosumab) on bone quality: a systematic review.
Gallacher SJ; Dixon T
Calcif Tissue Int; 2010 Dec; 87(6):469-84. PubMed ID: 20872215
[TBL] [Abstract][Full Text] [Related]
15. How to manage postmenopausal osteoporosis?
Body JJ
Acta Clin Belg; 2011; 66(6):443-7. PubMed ID: 22338309
[TBL] [Abstract][Full Text] [Related]
16. Drug-Related Adverse Events of Osteoporosis Therapy.
Khan M; Cheung AM; Khan AA
Endocrinol Metab Clin North Am; 2017 Mar; 46(1):181-192. PubMed ID: 28131131
[TBL] [Abstract][Full Text] [Related]
17. Atypical femoral fractures during prolonged use of bisphosphonates: short-term responses to strontium ranelate and teriparatide.
Carvalho NN; Voss LA; Almeida MO; Salgado CL; Bandeira F
J Clin Endocrinol Metab; 2011 Sep; 96(9):2675-80. PubMed ID: 21752890
[TBL] [Abstract][Full Text] [Related]
18. Prevention of osteoporosis: one step forward, two steps back.
Stevenson JC
Menopause Int; 2011 Dec; 17(4):137-41. PubMed ID: 22120943
[TBL] [Abstract][Full Text] [Related]
19. Benefit-risk assessment of raloxifene in postmenopausal osteoporosis.
Cranney A; Adachi JD
Drug Saf; 2005; 28(8):721-30. PubMed ID: 16048357
[TBL] [Abstract][Full Text] [Related]
20. New findings with old drugs for osteoporosis.
Doggrell SA
Expert Opin Pharmacother; 2009 Feb; 10(3):513-6. PubMed ID: 19191686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
